Leverage Shares PLC Intraday Rebalance -3x Moderna (5896J)

TIDMMRNS TIDMSMRN TIDMSMRE

RNS Number : 5896J

Leverage Shares PLC

13 December 2022

Leverage Shares plc

13 December 2022

THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF THE HOLDERS OF THE ETP SECURITIES. IF ANY ETP SECURITYHOLDER IS IN ANY DOUBT AS TO THE ACTION THEY SHOULD TAKE, THEY SHOULD CONSULT THEIR OWN INDEPENDENT PROFESSIONAL ADVISERS IMMEDIATELY

If you have recently sold or otherwise transferred your entire holding(s) of ETP Securities referred to below, you should immediately forward this document to the purchaser or transferee or to the stockbroker, bank or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee.

NOTICE OF INTRADAY REBALANCE

Leverage Shares plc (the ("Issuer") hereby gives notice that at 09:32:25 EST on 13 December 2022 (the "Trigger Time"), the price of Moderna Inc. (the "Reference Asset") for the Leverage Shares -3x Short Moderna (MRNA) ETP Securities (ISIN: XS2399366108) (the "ETP Securities") reached a trading price of $192.70 on exchange (the "Trigger Value"), representing a increase of 16.70% from its previous closing price of $165.13, thereby crossing the 16.67% set in the index methodology for the iSTOXX Inverse Leveraged -3x MRNA Index (the "Index").

This event triggered an intraday rebalance of the Index, which in turn triggered an intraday rebalance of the ETP Securities as provided in the Prospectus for the ETP Securities: https://leverageshares.com/documents/prospectus/Leverage-Shares-Base-Prospectus-16-May-2022.pdf?x93486 (the "Prospectus").

Starting 5 minutes after the Trigger Time, the Issuer carried out an intraday rebalance over the 10-minute period following the Trigger Time using the Trigger Value as the reference (the "Intraday Rebalance"), achieving an average price of $195.88805 and setting an ETP Security Value of $0.27874 (the "Rebalanced ETP Security Value").

Terms used but not defined in this notice shall bear the meanings assigned to them in the Prospectus.

If you have any queries arising from this notice, please contact us at [e-mail] .

Yours sincerely

The Directors

Leverage Shares plc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCEAKADFAPAFFA

(END) Dow Jones Newswires

December 13, 2022 11:30 ET (16:30 GMT)